#159684

Anti-Fibrinogen-like Protein 1 [177 m01]

Cat. #159684

Anti-Fibrinogen-like Protein 1 [177 m01]

Cat. #: 159684

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-5 days

Target: Fibrinogen-like Protein 1

Class: Monoclonal

Application: ELISA

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Leiping Chen

Institute: Yale University

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-Fibrinogen-like Protein 1 [177 m01]
  • Alternate name: FGL-1
  • Research fields: Immunology
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Reactivity: Human
  • Host: Mouse
  • Application: ELISA
  • Description: Fibrinogen-like Protein 1 (FLG-1) is secreted liver protein and inhibits antigen-specific T cell activation. FLG-1 binds to lymphocyte-activation gene 3 (LAG3), independent from MHC-Class II. FLG-1 ablation in mice promotes T cell immunity. FLG1 is shown to be highly produced in cancer cells.
  • Isotype: IgG1 kappa

Target Details

  • Target: Fibrinogen-like Protein 1
  • Target background: Fibrinogen-like Protein 1 (FLG-1) is secreted liver protein and inhibits antigen-specific T cell activation. FLG-1 binds to lymphocyte-activation gene 3 (LAG3), independent from MHC-Class II. FLG-1 ablation in mice promotes T cell immunity. FLG1 is shown to be highly produced in cancer cells.

Applications

  • Application: ELISA

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Shipping at 4° C

References

  • Wang et al. 2019. Cell. 176(1-2):334-347.e12. PMID: 30580966.